Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
All Genders
NCT07319546

Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty

Led by Mahidol University · Updated on 2026-01-06

32

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of this double-blind randomized controlled trial is to evaluate the effectiveness of an accelerated rehabilitation protocol on knee joint function and quality of life in individuals undergoing TKA compared to conventional rehabilitation in Dali, Yunan, China. The study will include patients aged 50-80 years who are scheduled for primary unilateral TKA. Participants will be randomly assigned to either an accelerated rehabilitation group or conventional rehabilitation group. The primary outcomes will include knee joint function, assessed using the KOOS and quality of life measures using the SF-36 surveys. The study will follow participants for 6 months post-surgery to assess longer-term outcomes. This study will not include individuals undergoing revision TKA or those with severe comorbid conditions. The results will provide critical insights into the role of accelerated rehabilitation in improving post-operative recovery, functional outcomes, and overall quality of life for TKA patients.

CONDITIONS

Official Title

Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty

Who Can Participate

Age: 50Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with end-stage knee OA necessitating primary unilateral TKA.
  • Aged between 50 and 80 years.
Not Eligible

You will not qualify if you...

  • History of joint infections, cancer, or inflammatory arthritis.
  • End-stage OA from rheumatoid or septic arthritis.
  • Neurological disorders such as Alzheimer's disease, Parkinson's disease, or stroke.
  • Unable to follow a structured rehabilitation protocol.
  • Previous knee surgeries other than arthroscopy.
  • Severe comorbidities hindering participation, such as advanced cardiovascular diseases.
  • Severe osteoporosis.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital

Dali, Yunnan, China

Actively Recruiting

Loading map...

Research Team

L

Liying Yang, PT, M.Sc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here